Y-Intercept (HK)
KLRA icon

Y-Intercept (HK)’s Kailera Therapeutics KLRA Stock Holding History

Y-Intercept (HK)’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$790K Buy
+69,168
New +$1.17M 0.02% 1109

Other funds holding KLRA

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Y-Intercept (HK)'s KLRA Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 69,168 shares worth $790K. The stake represents 0.02% of the portfolio and ranks #1109 among its holdings.

7 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Y-Intercept (HK) held 69,168 shares of Kailera Therapeutics worth $790K as of Q3 2026.
  • Kailera Therapeutics was a new Y-Intercept (HK) position in Q3 2026.
  • Kailera Therapeutics made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1109 holding.
  • 7 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.